Skip to main content
icon for How many West Nile neuroinvasive disease cases will be reported among New York City residents in 2026?

How many West Nile neuroinvasive disease cases will be reported among New York City residents in 2026?

icon for How many West Nile neuroinvasive disease cases will be reported among New York City residents in 2026?

How many West Nile neuroinvasive disease cases will be reported among New York City residents in 2026?

35 to 49 28%

20 to 34 22%

50 or more 11%

Fewer than 20 6%

Polymarket
NOWE

35 to 49 28%

20 to 34 22%

50 or more 11%

Fewer than 20 6%

Polymarket
NOWE

Fewer than 20

$55 Wol.

25%

20 to 34

$67 Wol.

22%

35 to 49

$454 Wol.

28%

50 or more

$221 Wol.

11%

This market resolves based on the total number of West Nile neuroinvasive disease cases (encephalitis, meningitis, and acute flaccid paralysis) reported among New York City residents in 2026, as published by the New York City Department of Health and Mental Hygiene on its West Nile Virus Reports page at nyc.gov/site/doh/health/health-topics/west-nile-virus-reports.page. Cases are counted as whole numbers, so each outcome covers a distinct range with no overlap or gap. The 2026 count shown on the source as of January 1, 2027 is the starting figure. If the DOHMH publishes or revises the 2026 count on or after January 1, 2027, this market will resolve based on the count shown on the source at 11:59 PM ET on the 14th day after the first such update, or on March 31, 2027, 11:59 PM ET, whichever comes first. If no such update occurs, this market will resolve on March 31, 2027, 11:59 PM ET, based on the 2026 count shown on the source at that time. If no 2026 count has been published on the source by March 31, 2027, 11:59 PM ET, this market will resolve based on the sum of 2026 West Nile neuroinvasive disease case counts reported by CDC ArboNET for the five New York City counties (Bronx, Kings, New York, Queens, and Richmond). Revisions published after this market resolves will not be considered. If the DOHMH changes its reporting format or URL structure, the closest equivalent NYC Health Department publication of 2026 West Nile neuroinvasive case data will be used.Elevated West Nile virus activity in mosquitoes across all NYC boroughs since mid-June, with 1,284 positive pools reported—nearly double the prior year's pace at this point—drives current market sentiment amid only one confirmed neuroinvasive case as of August 19. Peak transmission typically occurs in August and September, when warmer temperatures and mosquito abundance can accelerate spread, though enhanced larviciding and public precautions may limit severe outcomes. Historical data show recent annual neuroinvasive averages of 25–31 cases among residents (range 16–36 from 2021–2025), versus lower prior baselines, creating uncertainty between bins below 20 and 35–49 given variable reporting lags, weather influences on vectors, and the roughly 1-in-150 infection-to-neuroinvasive ratio. Surveillance updates from the NYC Health Department through October will clarify final counts.

This market resolves based on the total number of West Nile neuroinvasive disease cases (encephalitis, meningitis, and acute flaccid paralysis) reported among New York City residents in 2026, as published by the New York City Department of Health and Mental Hygiene on its West Nile Virus Reports page at nyc.gov/site/doh/health/health-topics/west-nile-virus-reports.page.

Cases are counted as whole numbers, so each outcome covers a distinct range with no overlap or gap.

The 2026 count shown on the source as of January 1, 2027 is the starting figure.

If the DOHMH publishes or revises the 2026 count on or after January 1, 2027, this market will resolve based on the count shown on the source at 11:59 PM ET on the 14th day after the first such update, or on March 31, 2027, 11:59 PM ET, whichever comes first. If no such update occurs, this market will resolve on March 31, 2027, 11:59 PM ET, based on the 2026 count shown on the source at that time.

If no 2026 count has been published on the source by March 31, 2027, 11:59 PM ET, this market will resolve based on the sum of 2026 West Nile neuroinvasive disease case counts reported by CDC ArboNET for the five New York City counties (Bronx, Kings, New York, Queens, and Richmond). Revisions published after this market resolves will not be considered. If the DOHMH changes its reporting format or URL structure, the closest equivalent NYC Health Department publication of 2026 West Nile neuroinvasive case data will be used.
Wolumen
$796
Data zakończenia
Mar 31, 2027
Rynek otwarty
Aug 20, 2026, 5:18 PM ET
This market resolves based on the total number of West Nile neuroinvasive disease cases (encephalitis, meningitis, and acute flaccid paralysis) reported among New York City residents in 2026, as published by the New York City Department of Health and Mental Hygiene on its West Nile Virus Reports page at nyc.gov/site/doh/health/health-topics/west-nile-virus-reports.page. Cases are counted as whole numbers, so each outcome covers a distinct range with no overlap or gap. The 2026 count shown on the source as of January 1, 2027 is the starting figure. If the DOHMH publishes or revises the 2026 count on or after January 1, 2027, this market will resolve based on the count shown on the source at 11:59 PM ET on the 14th day after the first such update, or on March 31, 2027, 11:59 PM ET, whichever comes first. If no such update occurs, this market will resolve on March 31, 2027, 11:59 PM ET, based on the 2026 count shown on the source at that time. If no 2026 count has been published on the source by March 31, 2027, 11:59 PM ET, this market will resolve based on the sum of 2026 West Nile neuroinvasive disease case counts reported by CDC ArboNET for the five New York City counties (Bronx, Kings, New York, Queens, and Richmond). Revisions published after this market resolves will not be considered. If the DOHMH changes its reporting format or URL structure, the closest equivalent NYC Health Department publication of 2026 West Nile neuroinvasive case data will be used.
This market resolves based on the total number of West Nile neuroinvasive disease cases (encephalitis, meningitis, and acute flaccid paralysis) reported among New York City residents in 2026, as published by the New York City Department of Health and Mental Hygiene on its West Nile Virus Reports page at nyc.gov/site/doh/health/health-topics/west-nile-virus-reports.page. Cases are counted as whole numbers, so each outcome covers a distinct range with no overlap or gap. The 2026 count shown on the source as of January 1, 2027 is the starting figure. If the DOHMH publishes or revises the 2026 count on or after January 1, 2027, this market will resolve based on the count shown on the source at 11:59 PM ET on the 14th day after the first such update, or on March 31, 2027, 11:59 PM ET, whichever comes first. If no such update occurs, this market will resolve on March 31, 2027, 11:59 PM ET, based on the 2026 count shown on the source at that time. If no 2026 count has been published on the source by March 31, 2027, 11:59 PM ET, this market will resolve based on the sum of 2026 West Nile neuroinvasive disease case counts reported by CDC ArboNET for the five New York City counties (Bronx, Kings, New York, Queens, and Richmond). Revisions published after this market resolves will not be considered. If the DOHMH changes its reporting format or URL structure, the closest equivalent NYC Health Department publication of 2026 West Nile neuroinvasive case data will be used.Elevated West Nile virus activity in mosquitoes across all NYC boroughs since mid-June, with 1,284 positive pools reported—nearly double the prior year's pace at this point—drives current market sentiment amid only one confirmed neuroinvasive case as of August 19. Peak transmission typically occurs in August and September, when warmer temperatures and mosquito abundance can accelerate spread, though enhanced larviciding and public precautions may limit severe outcomes. Historical data show recent annual neuroinvasive averages of 25–31 cases among residents (range 16–36 from 2021–2025), versus lower prior baselines, creating uncertainty between bins below 20 and 35–49 given variable reporting lags, weather influences on vectors, and the roughly 1-in-150 infection-to-neuroinvasive ratio. Surveillance updates from the NYC Health Department through October will clarify final counts.

This market resolves based on the total number of West Nile neuroinvasive disease cases (encephalitis, meningitis, and acute flaccid paralysis) reported among New York City residents in 2026, as published by the New York City Department of Health and Mental Hygiene on its West Nile Virus Reports page at nyc.gov/site/doh/health/health-topics/west-nile-virus-reports.page.

Cases are counted as whole numbers, so each outcome covers a distinct range with no overlap or gap.

The 2026 count shown on the source as of January 1, 2027 is the starting figure.

If the DOHMH publishes or revises the 2026 count on or after January 1, 2027, this market will resolve based on the count shown on the source at 11:59 PM ET on the 14th day after the first such update, or on March 31, 2027, 11:59 PM ET, whichever comes first. If no such update occurs, this market will resolve on March 31, 2027, 11:59 PM ET, based on the 2026 count shown on the source at that time.

If no 2026 count has been published on the source by March 31, 2027, 11:59 PM ET, this market will resolve based on the sum of 2026 West Nile neuroinvasive disease case counts reported by CDC ArboNET for the five New York City counties (Bronx, Kings, New York, Queens, and Richmond). Revisions published after this market resolves will not be considered. If the DOHMH changes its reporting format or URL structure, the closest equivalent NYC Health Department publication of 2026 West Nile neuroinvasive case data will be used.
Wolumen
$796
Data zakończenia
Mar 31, 2027
Rynek otwarty
Aug 20, 2026, 5:18 PM ET
This market resolves based on the total number of West Nile neuroinvasive disease cases (encephalitis, meningitis, and acute flaccid paralysis) reported among New York City residents in 2026, as published by the New York City Department of Health and Mental Hygiene on its West Nile Virus Reports page at nyc.gov/site/doh/health/health-topics/west-nile-virus-reports.page. Cases are counted as whole numbers, so each outcome covers a distinct range with no overlap or gap. The 2026 count shown on the source as of January 1, 2027 is the starting figure. If the DOHMH publishes or revises the 2026 count on or after January 1, 2027, this market will resolve based on the count shown on the source at 11:59 PM ET on the 14th day after the first such update, or on March 31, 2027, 11:59 PM ET, whichever comes first. If no such update occurs, this market will resolve on March 31, 2027, 11:59 PM ET, based on the 2026 count shown on the source at that time. If no 2026 count has been published on the source by March 31, 2027, 11:59 PM ET, this market will resolve based on the sum of 2026 West Nile neuroinvasive disease case counts reported by CDC ArboNET for the five New York City counties (Bronx, Kings, New York, Queens, and Richmond). Revisions published after this market resolves will not be considered. If the DOHMH changes its reporting format or URL structure, the closest equivalent NYC Health Department publication of 2026 West Nile neuroinvasive case data will be used.

Uważaj na linki zewnętrzne.

Często zadawane pytania

"How many West Nile neuroinvasive disease cases will be reported among New York City residents in 2026?" to rynek prognoz na Polymarket z 4 możliwymi wynikami, gdzie traderzy kupują i sprzedają udziały na podstawie tego, co ich zdaniem się wydarzy. Obecny wiodący wynik to "35 to 49" z 28%, za nim "Fewer than 20" z 25%. Ceny odzwierciedlają zbiorowe prawdopodobieństwa w czasie rzeczywistym. Na przykład udział wyceniony na 28¢ implikuje, że rynek zbiorowo przypisuje 28% szansy na ten wynik. Te kursy zmieniają się ciągle, gdy traderzy reagują na nowe informacje. Udziały w poprawnym wyniku można wymienić na $1 za sztukę po rozstrzygnięciu rynku.

"How many West Nile neuroinvasive disease cases will be reported among New York City residents in 2026?" to nowo utworzony rynek na Polymarket, uruchomiony Aug 20, 2026. Jako wczesny rynek, to Twoja okazja, aby być jednym z pierwszych traderów, którzy ustalą kursy i określą początkowe sygnały cenowe rynku. Możesz też dodać tę stronę do zakładek, aby śledzić wolumen i aktywność handlową w miarę rozwoju rynku.

Aby handlować na "How many West Nile neuroinvasive disease cases will be reported among New York City residents in 2026?", przeglądaj 4 dostępnych wyników na tej stronie. Każdy wynik wyświetla bieżącą cenę reprezentującą implikowane prawdopodobieństwo rynku. Aby zająć pozycję, wybierz wynik, który uważasz za najbardziej prawdopodobny, wybierz "Tak", aby handlować na jego korzyść, lub "Nie", aby handlować przeciw niemu, wpisz kwotę i kliknij "Handluj". Jeśli wybrany wynik okaże się poprawny, Twoje udziały "Tak" wypłacą $1 za sztukę. Jeśli jest niepoprawny, wypłacą $0. Możesz też sprzedać swoje udziały w dowolnym momencie przed rozstrzygnięciem.

Obecnym faworytem dla "How many West Nile neuroinvasive disease cases will be reported among New York City residents in 2026?" jest "35 to 49" z 28%, co oznacza, że rynek przypisuje 28% szansy na ten wynik. Następny najbliższy wynik to "Fewer than 20" z 25%. Te kursy aktualizują się w czasie rzeczywistym, gdy traderzy kupują i sprzedają udziały, odzwierciedlając najnowszy zbiorowy pogląd na to, co jest najbardziej prawdopodobne. Sprawdzaj regularnie lub dodaj tę stronę do zakładek, aby śledzić zmiany kursów.

Zasady rozstrzygania "How many West Nile neuroinvasive disease cases will be reported among New York City residents in 2026?" określają dokładnie, co musi się wydarzyć, aby każdy wynik został ogłoszony zwycięzcą — w tym oficjalne źródła danych używane do ustalenia wyniku. Możesz przejrzeć pełne kryteria rozstrzygania w sekcji "Zasady" na tej stronie nad komentarzami. Zalecamy dokładne zapoznanie się z zasadami przed handlem, ponieważ określają one precyzyjne warunki, przypadki graniczne i źródła regulujące rozstrzyganie tego rynku.